✦ LIBER ✦

Toward Individualized Cholesterol-Lowering Treatment in End-Stage Renal Disease

✍ Scribed by Silbernagel, Guenther; Baumgartner, Iris; Wanner, Christoph; März, Winfried

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reasons for the Lack of Salutary Effects

✍ Vaziri, Nosratola D.; Norris, Keith C. 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 154 KB

Treatment of hyperhomocysteinemia in end

✍ Douglas Shemin; Andrew G. Bostom; Jacob Selhub 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Increased risk of end-stage renal diseas

✍ Welander, A.; Prutz, K.-G.; Fored, M.; Ludvigsson, J. F. 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 104 KB

Towards guidelines for dialysis in child

✍ I. Riaño; S. Malaga; L. Callis; C. Loris; J. Martin-Govantes; M. Navarro; A. Val 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 40 KB

End-stage renal disease in Brazil: Epide

✍ Oliveira, Marilia Bahiense; Romao, Joao Egidio; Zatz, Roberto 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Treatment Bias in the Management of End-

✍ Smith, Marc D.; Hong, Barry A.; Michelman, Jeffrey E.; Robson, Alan M. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 519 KB